See What HealthDay Can Do For You
Contact Us

Cardiac Events Seen With β-Blockers, Surgical Anemia

β-blockers linked to adverse events after non-cardiac surgery if hemoglobin falls >35 percent

TUESDAY, Jan. 5 (HealthDay News) -- Patients undergoing non-cardiac surgery who develop acute surgical anemia are more likely to have major cardiac complications and mortality if they receive perioperative β-blockers, according to research published in the January issue of Anesthesiology.

W. Scott Beattie, M.D., of the University of Toronto, and colleagues analyzed data from 4,387 patients who underwent major non-cardiac surgeries. The primary outcome was major adverse cardiac events, comprising myocardial infarction, nonfatal cardiac arrest, and in-hospital mortality.

The researchers found that major adverse cardiac events were more likely to occur in β-blocked patients (relative risk, 2.38). However, β-blockers were only associated with higher risk when patients had a decrease in hemoglobin of greater than 35 percent.

"We have shown that acute surgical anemia, a reduction of 35 percent from baseline, increased the risk of cardiac outcomes. This relationship is much worse in β-blocked patients. These findings suggest that the transfusion triggers should be higher for elective surgical patients on β-blockers. Owing to the relatively low risk of our population, we are unable to extend these finding to higher risk β-blocked patients who have been shown in the past to have reduced cardiac outcomes," the authors conclude.

Full Text

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.